|
|
Last Modified: 6/9/2008  First Published: 9/26/2007 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III, Phase II
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
4 and over
|
|
|
|
NCI
|
|
|
|
RPCI-I-72806 I 72806, NCT00536601
|
|
|
|
|
|
|
|
Last Modified: 10/6/2008  First Published: 8/18/2006 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care, Treatment
|
|
|
|
Active
|
|
|
|
3 to 20
|
|
|
|
NCI
|
|
|
|
MCC-0402 NCT00369564, ACCL 0731
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care, Treatment
|
|
|
|
Active
|
|
|
|
15 and over
|
|
|
|
Other
|
|
|
|
2004-0107 NCT00500240
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
Not specified
|
|
|
|
Other
|
|
|
|
MSKCC-95024 NCI-V95-0685, NCT00002663
|
|
|
|
|
|
|
|
Last Modified: 5/22/2008  First Published: 2/1/2008 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Biomarker/Laboratory analysis, Treatment
|
|
|
|
Active
|
|
|
|
1 to 75
|
|
|
|
NCI
|
|
|
|
NCI-08-C-0051 08-C-0051, NCI-P06049, NCT00608166
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
0 to 55
|
|
|
|
Other
|
|
|
|
8717 NCT00673114
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
1 to 17
|
|
|
|
Other
|
|
|
|
SUN08-01 NCT00704054
|
|
|
|
|
|
|
|
Last Modified: 7/11/2007  First Published: 1/1/2001 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
65 and under
|
|
|
|
NCI
|
|
|
|
CPMC-IRB-AAAA5571 CPMC-CAMP-016, NCI-G00-1891, NCT00008216
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
18 and over for Burkitt's lymphoma
|
|
|
|
NCI
|
|
|
|
NCI-93-C-0133 CRB-9307, NCI-MB-303, NCI-T93-0023N, T93-0023, NCT00018980
|
|
|
|
|
|
|
|
Last Modified: 10/17/2008  First Published: 3/24/2003 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
1 to 29
|
|
|
|
NCI
|
|
|
|
COG-ANHL01P1 NCT00057811, ANHL01P1
|
|
|
|